SDGR Quote, Financials, Valuation and Earnings

Simulations Plus has a net margin of -45.54% compared to Schrodinger's net margin of 1.09%. Schrodinger's return on equity of -38.87% beat Simulations Plus's return on equity of 4.58%.

Schrodinger has a consensus price target of $32.09, signalling upside risk potential of 47.21%. On the other hand Simulations Plus has an analysts' consensus of $49.40 which suggests that it could grow by 93.31%. Given that Simulations Plus has higher upside potential than Schrodinger, analysts believe Simulations Plus is more attractive than Schrodinger.

Schrodinger has a beta of 1.624, which suggesting that the stock is 62.426% more volatile than S&P 500. In comparison Simulations Plus has a beta of 0.894, suggesting its less volatile than the S&P 500 by 10.602%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.94% to investors and pays a quarterly dividend of $0.06 per share. Schrodinger pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Schrodinger quarterly revenues are $88.3M, which are larger than Simulations Plus quarterly revenues of $18.9M. Schrodinger's net income of -$40.2M is lower than Simulations Plus's net income of $206K. Notably, Schrodinger's price-to-earnings ratio is -- while Simulations Plus's PE ratio is 63.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.63x versus 6.97x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

Veeva Systems has a net margin of -45.54% compared to Schrodinger's net margin of 27.14%. Schrodinger's return on equity of -38.87% beat Veeva Systems's return on equity of 13.71%.

Schrodinger has a consensus price target of $32.09, signalling upside risk potential of 47.21%. On the other hand Veeva Systems has an analysts' consensus of $266.49 which suggests that it could grow by 12.55%. Given that Schrodinger has higher upside potential than Veeva Systems, analysts believe Schrodinger is more attractive than Veeva Systems.

Schrodinger has a beta of 1.624, which suggesting that the stock is 62.426% more volatile than S&P 500. In comparison Veeva Systems has a beta of 0.883, suggesting its less volatile than the S&P 500 by 11.727%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $88.3M, which are smaller than Veeva Systems quarterly revenues of $720.9M. Schrodinger's net income of -$40.2M is lower than Veeva Systems's net income of $195.6M. Notably, Schrodinger's price-to-earnings ratio is -- while Veeva Systems's PE ratio is 54.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.63x versus 14.22x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of -45.54% compared to Schrodinger's net margin of --. Schrodinger's return on equity of -38.87% beat Nano Mobile Healthcare's return on equity of --.

Schrodinger has a consensus price target of $32.09, signalling upside risk potential of 47.21%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrodinger has higher upside potential than Nano Mobile Healthcare, analysts believe Schrodinger is more attractive than Nano Mobile Healthcare.

Schrodinger has a beta of 1.624, which suggesting that the stock is 62.426% more volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -0.644, suggesting its less volatile than the S&P 500 by 164.377%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $88.3M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Schrodinger's net income of -$40.2M is higher than Nano Mobile Healthcare's net income of --. Notably, Schrodinger's price-to-earnings ratio is -- while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.63x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Xsovt Brands has a net margin of -45.54% compared to Schrodinger's net margin of --. Schrodinger's return on equity of -38.87% beat Xsovt Brands's return on equity of --.

Schrodinger has a consensus price target of $32.09, signalling upside risk potential of 47.21%. On the other hand Xsovt Brands has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrodinger has higher upside potential than Xsovt Brands, analysts believe Schrodinger is more attractive than Xsovt Brands.

Schrodinger has a beta of 1.624, which suggesting that the stock is 62.426% more volatile than S&P 500. In comparison Xsovt Brands has a beta of 5.709, suggesting its more volatile than the S&P 500 by 470.861%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xsovt Brands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Xsovt Brands pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $88.3M, which are larger than Xsovt Brands quarterly revenues of --. Schrodinger's net income of -$40.2M is higher than Xsovt Brands's net income of --. Notably, Schrodinger's price-to-earnings ratio is -- while Xsovt Brands's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.63x versus -- for Xsovt Brands. Usually stocks with elevated PS ratios are considered overvalued.